logo
15:59 Dec 05

SMS Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
317.00
-5.45 (-1.69%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

SMS Pharmaceuticals Ltd. Financials

SMS Pharmaceuticals Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
317.00
-5.45 (-1.69%)
15:59 Dec 05
Quality
image/svg+xml

77/100
High Financial Strength

Valuation
image/svg+xml

40/100
Mid Valuation

Technical

67/100
Technically Moderately Bullish

Strength

15

Weakness

3

Opportunity

1

Threats

1

10.80 %

ROE %

5.99 %

ROA %

9.52

EPS

72.15

BVPS

8.83 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
519.87 522.05 709.26 782.75 860.03
Operating Expenses +
405.54 467.54 592.64 643.76 698.26
Raw Material
387.95 299.73 425.26 501.87 489.08
Increase Decrease in Cost
-112.5 36.08 -1 -64.81 -4.89
Other Manufacturing Expense
55.04 57.31 73.44 0 0
Employee Cost
51.02 55.04 64.15 80.08 82.7
Miscellaneous Expenses
24.03 19.38 30.79 126.62 131.37
Operating Profit
114.33 54.51 116.62 138.99 161.77
Other Income
5.2 4.89 4.46 6.22 5.57
Depreciation
32.15 32.13 31.52 34.34 37.11
Interest
18.88 21.92 23.46 18.54 20.85
Profit before tax and exceptio..
68.5 5.35 66.11 92.34 109.38
Exceptional Items
0 0 0 0 0
PBT
68.5 5.35 66.11 92.34 109.38
Provision for Taxation
0.62 1.46 16.91 24.94 28.36
Net Profit
67.88 3.88 49.2 67.4 81
NET Profit after MI
62.22 -7.06 49.83 69.14 84.36
EPS
7.35 -0.83 5.89 8.16 9.7
Operating Profit Margin (%)
21.99 10.44 16.44 17.76 18.81
Net Profit Margin (%)
11.97 -1.35 7.03 8.83 9.81

SMS Pharmaceuticals Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 68.10 66.30 66.30 64.70 64.70 64.70
FII 0.30 0.00 0.10 0.30 0.50 0.20
Public 2.90 3.10 2.40 2.60 2.60 2.10
Others 28.70 30.60 31.20 32.40 32.20 33.00
Shareholder Shares Holding %
Research 360 logo
Download Our App On: